The Global Market for Chitin and Chitosan Derivatives is Projected to Reach 220.3 Metric Tons by the Year 2024

Growing Use in Agrochemicals and Healthcare to Drive Global Demand for Chitin and Chitosan Derivatives, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market size, share and demand forecasts on the global Chitin and Chitosan Derivatives market. The global market for Chitin and Chitosan Derivatives is projected to reach 220.3 metric tons by the year 2024, driven by increasing preference for these biopolymers due to easy availability, non-toxicity and biodegradability along with growing research evidence in support of the material across various applications.  

Chitin is one of the most abundantly found natural biopolymers, which is gaining significant growth in adoption in a range of applications. Chitosan, a natural polycationic polymer, is a deacetylated form of chitin. Found in abundance in nature and synthesized to suit various end-use applications through physical and chemical modifications, chitin and chitosan derivatives are a major focus of research interest in a plethora of applications. The renewable, degradable and recyclable properties of biopolymers make them the ‘preferred environmentally friendly’ products in various end-use sectors. These polymers find use in a wide range of applications ranging from antibiotics and surgical sutures to dietary supplements, food & pet foods to textiles and water treatment. Despite being used in a wide range of applications, chitin and chitosan remain an underutilized resource and the market remains untapped due in part to lack of awareness with respect to prospective applications of chitin and chitosan. Significant research work is underway supporting the benefits of chitosan in various end-use applications, which is expected to fuel significant market growth through the review period.  

Water Treatment represents the largest end-use application of chitosan worldwide. Increasing demand for scarce clean water, incited by growing industrialization and urbanization worldwide, along with rising pollution of water bodies are driving investments in water and wastewater treatment, which is benefiting demand for chitosan. The biopolymer derivative is preferred over competing products due to its non-toxic nature and biodegradability along with easy availability. Agrichemicals and Healthcare are other applications offering lucrative opportunities for chitosan Cosmetics & Toiletries, Healthcare and Agrochemicals. Characterized by unique biological properties such as antitumor, antimicrobial, and antioxidant activities, which enable its use in various biological and biomedical applications, demand for chitosan is fast growing in the area of healthcare. Growing support from research in its use as a drug delivery platform is expected to add momentum going forwards. Growing emphasis on increasing agricultural productivity and reducing toxicity is driving use of chitosan in soil and seed treatment applications in the area of agriculture, thereby driving its demand.  

As stated by the new market research report on Chitin and Chitosan Derivatives, Asia-Pacific represents the largest market worldwide in volume terms. Growing industrialization as well as urbanization in the region is driving demand for clean water in turn driving the market for chitin derivatives. The region also represents the fastest growing market worldwide, with a CAGR of 17.1% through the analysis period. Factors such as increasing incomes and changing lifestyles that are driving the market for Cosmetics & Toiletries, increasing market for various dietary supplements and growing focus on agricultural productivity, are expected to surge demand for chitosan in various end-use applications in the region.

Major players in the market include Advanced Biopolymers AS, G.T.C. Bio Corporation, Golden-Shell Pharmaceutical Co. Ltd., Heppe Medical Chitosan GmbH, Kitozyme, Kunpoong Bio Co. Ltd., KYTOSAN® USA LLC, Meron Biopolymers, Primex Ehf, Zhejiang Candorly Pharmaceutical Co. Ltd. and Zhejiang Shinfuda Marine Biotechnology Corp., among others.

The research report titled “Chitin and Chitosan Derivatives: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for Chitin Derivatives in volume terms for all major geographic markets such as United States, Canada, Europe, Asia-Pacific and Rest of World. Product segments analyzed include Manual Wheelchairs, Powered Wheelchairs and Mobility Scooters. Types of Chitin Derivates analyzes include Glucosamine, Chitosan and Others. The report also analyzes chitosan by the following end-use applications: Water Treatment, Cosmetics & Toiletries, Food & Beverages, Healthcare/Medical, Agrochemicals, Biotechnology and Others.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.